Back

Genomic discovery and functional validation of MRP1 as a novel fetal hemoglobin modulator and potential therapeutic target in sickle cell disease.

Butterworth, A. S.; Hara, Y.; Kawabata, E.; Lemgart, V.; Bronson, P.; Hicks, A.; Peters, R.; Krishnamoorthy, S.; Ribeil, J.-A.; Schmunk, L.; Eglinton, J.; Watkins, N. A.; Roberts, D. J.; Di Angelantonio, E.; Danesh, J.; Astle, W. J.; Paul, D. S.; Lessard, S.

2023-03-15 epidemiology
10.1101/2023.03.14.23287244 medRxiv
Show abstract

Sickle cell disease (SCD) remains a major health burden with limited treatment options. Despite promising gene-editing clinical trials, there is an unmet need for cost-effective therapies. As induction of fetal hemoglobin (HbF) is an established therapeutic strategy for SCD, we conducted a genome-wide association study of circulating HbF levels in ~11,000 participants to identify further HbF modulators. We identified associations in 11 genomic regions, including eight novel loci such as ABCC1 (encoding multidrug resistance-associated protein 1, MRP1). Using gene-editing and pharmacological approaches, we showed that inhibition of MRP1 increases HbF, intracellular glutathione levels, and reduces sickling in erythroid cells from SCD patients. Overall, our findings identify several novel genetically-validated potential therapeutic targets for SCD, including promising proof-of-principle results from small molecule inhibition of MRP1.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
eLife
● 5828 papers in training set
Top 2%
19.3%
Similar papers in this journal
2
Blood Advances
● 62 papers in training set
Top 0.2%
7.6%
Similar papers in this journal
3
Nature Communications
○ 5641 papers in training set
Top 25%
6.5%
Similar papers in this journal
4
Haematologica
● 25 papers in training set
Top 0.1%
6.5%
Similar papers in this journal
5
EMBO Molecular Medicine
○ 95 papers in training set
Top 0.1%
5.0%
Similar papers in this journal
6
Journal of Clinical Investigation
● 179 papers in training set
Top 1%
4.5%
7
The American Journal of Human Genetics
○ 234 papers in training set
Top 1%
3.7%
50% of probability mass above
8
Science Translational Medicine
● 127 papers in training set
Top 0.9%
2.7%
9
PLOS Genetics
● 862 papers in training set
Top 5%
2.5%
10
Life Science Alliance
● 285 papers in training set
Top 2%
2.2%
11
PLOS ONE
● 5266 papers in training set
Top 45%
1.8%
12
Science Advances
● 1243 papers in training set
Top 19%
1.8%
13
Communications Biology
○ 993 papers in training set
Top 16%
1.6%
14
Cell Reports Medicine
○ 153 papers in training set
Top 3%
1.6%
15
Molecular Therapy
○ 81 papers in training set
Top 1%
1.4%
16
Scientific Reports
○ 3612 papers in training set
Top 59%
1.4%
17
Blood
● 74 papers in training set
Top 0.9%
1.4%
18
Frontiers in Genetics
○ 230 papers in training set
Top 3%
1.4%
19
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 33%
1.2%
20
British Journal of Haematology
○ 15 papers in training set
Top 0.1%
1.2%
21
Circulation: Genomic and Precision Medicine
○ 48 papers in training set
Top 0.7%
1.2%
22
BMC Medicine
○ 176 papers in training set
Top 3%
1.2%
23
iScience
○ 1154 papers in training set
Top 29%
1.1%
24
Journal of Thrombosis and Haemostasis
○ 32 papers in training set
Top 0.3%
1.0%
25
Cellular and Molecular Life Sciences
○ 96 papers in training set
Top 2%
0.9%
26
eBioMedicine
○ 183 papers in training set
Top 6%
0.9%
27
Experimental Hematology
○ 11 papers in training set
Top 0.2%
0.9%
28
Journal of Experimental Medicine
● 119 papers in training set
Top 3%
0.6%
29
Stem Cell Reports
○ 130 papers in training set
Top 2%
0.6%
30
Human Molecular Genetics
◐ 141 papers in training set
Top 3%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.